Big Investor Watch
Yasuko Oka Cuts Stake in J.S.B. (3480) to 0% | Large Shareholding Report
IndividualSell

Yasuko Oka Cuts Stake in J.S.B. (3480) to 0% | Large Shareholding Report

Stock
ジェイ・エス・ビー (3480) — holding history (Japanese)
Deal date
Deal size
¥73.8B
Filer
岡 靖子

A large shareholding report (EDINET filing) shows that Yasuko Oka has reduced her stake in J.S.B. (3480) to 0%. The company manufactures and sells pharmaceutical and medical devices while conducting related research and development, with Oka's complete exit marking the disappearance of a multi-hundred-billion-yen shareholding position.

Stake Reduced from 32.73% to Zero Within One Month

Yasuko Oka first disclosed her holdings in J.S.B. on June 18, 2026, with a stake of 32.73%. By July 30, a change report showed the holding at 0%, meaning the entire position was disposed of within that month. The transaction was conducted off-market through a related-party trade with Ursa 4 Corporation as counterparty.

ジェイ・エス・ビー: reported stake held by 岡 靖子 over time
Reported stake in ジェイ・エス・ビー held by 岡 靖子, by EDINET filing date.

¥64.69 Billion Transfer at ¥9,000 Per Share

The transfer price was set at ¥9,000 per share for 7,187,800 shares. With J.S.B.'s market price at ¥9,230 on the disclosure date, Oka sold at approximately ¥230 per share below prevailing market levels. Proceeds from the transaction totaled ¥64.69 billion.

From Dominant Shareholder to Complete Exit

Prior to Oka's full exit, the largest disclosed shareholder was Kotsutransmission at 6.77%, followed by Nomura Securities at 0.01% and Neuberger Berman at 0%. Oka's 32.73% stake positioned her as the company's leading shareholder by a vast margin. That position has now completely unwound, fundamentally altering the shareholder structure going forward.

Large shareholders of ジェイ・エス・ビー by reported stake
Investors that have filed large shareholding reports on ジェイ・エス・ビー (岡 靖子 highlighted).

Elevated Valuation Metrics Reflected in Stock Price

At the filing date, J.S.B. traded at a PER of 36.9x and PBR of 4.56x. The high PER indicates the market prices the company's current earnings at a premium, while elevated PBR suggests the share price significantly exceeds net asset value. The 52-week range indicator at 100% confirms the stock trades near its 12-month high.

*Speculation: The exit from a long-standing stake in this medical device manufacturer may reflect a strategic portfolio reallocation or liquidity needs on the part of the major shareholder.

ジェイ・エス・ビー (3480) share price, last three months
Share price of ジェイ・エス・ビー (3480) over the last three months (closing prices).

Deal size is an estimate (shares outstanding × share price × change in holding ratio); EDINET filings do not state a yen amount. This article is generated from the filing's facts and is not investment advice. Read the Japanese edition of this article for the latest data.

Related articles